Nova Scotia Health Authority

New "One Person One Record" program prioritizes the modernization of information systems with Infor Healthcare Revenue Cycle Management application NEW YORK, Jan. 23, 2024 /PRNewswire/ -- Infor®, the industry cloud company, today announced that Nova Scotia Health and IWK Health have selected the Infor Healthcare Revenue Cycle Management application to help meet the goals of its digital transformation program, One Person One Record (OPOR). This major program will replace health information systems used throughout the province of Nova Scotia with a new clinical information system. As part of the transformation, key Infor applications will be used to modernize and unify disparate patient accounting and billing systems. "During our selection process, Infor demonstrated its understanding of the vision and strategic direction of One Person One Record, and how billing systems are part of the overall transformation," said Scott McKenna, chief information officer, Nova Scotia Health and IWK Health. "This technology will consolidate and streamline client and patient billing, payments, and follow-up for cases such as out-of-country patients or uninsured patients." Nova Scotia Health is the largest provider of health services in Nova Scotia. Its workforce of over 24,000 provides healthcare and support services in hospitals, health centers, and community-based programs across the province. IWK Health provides collaborative high-quality care to women, children, youth, and families in the Maritime provinces and beyond. Services are delivered through our Children's Health program, Mental Health and Addictions program, and Women's and Newborn Health. IWK Health's approach integrates talented people with new technologies, research, training, and clinical excellence to provide complex levels of care across our region. Nova Scotia is currently undergoing a multitude of groundbreaking digital health transformation projects aimed at revolutionizing healthcare delivery and improving the well-being of its citizens. These initiatives span a diverse range of areas, including electronic medical records implementation. "Modern healthcare organizations understand that their success depends on more than balancing the books every month. It is paramount that they focus on driving efficiencies through improved workflows and communications," said Travis Hatmaker, Infor senior vice president, industry and solution strategy. "Accurate and available patient accounts and related billing processes can make an enormous difference in improving overall efficiency. Infor is a trusted partner in the industry because we work with our customers to deeply understand the nuances of healthcare, beyond technology - we understand the difference between patient care and caring for the business, and we have a unique perspective on how to bring those two things together to solve the challenges that organizations are facing today." Learn more about Infor Healthcare: . About Infor Infor is a global leader in business cloud software specialized by industry. We develop complete solutions for our focus industries. Infor's mission-critical enterprise applications and services are designed to deliver sustainable operational advantages with security and faster time to value. Over 60,000 organizations in more than 175 countries rely on Infor's 17,000 employees to help achieve their business goals. As a Koch company, our financial strength, ownership structure, and long-term view empower us to foster enduring, mutually beneficial relationships with our customers. Visit . Media contact: Alexandria Truby Infor [email protected] 313-246-4268 Copyright ©2023 Infor. All rights reserved. The word and design marks set forth herein are trademarks and/or registered trademarks of Infor and/or related affiliates and subsidiaries. All other trademarks listed herein are the property of their respective owners. . SOURCE Infor

10-year multi-disciplinary oncology partnership builds on a long-standing relationship between Varian and Nova Scotia Health to improve clinical outcomes and drive value across the health system Commitment of up to $175 million CAD by Nova Scotia Health through the purchase of hardware, software, digital solutions, and services, and contributions to the development of a digital imaging concept Varian office to be established in Nova Scotia, employing a minimum of 60 full-time employees with a 10-year payroll/rent commitment of $50 million CAD PALO ALTO, Calif. and HALIFAX, NS, Jan. 4, 2024 /PRNewswire/ -- Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership (MDOP) designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship. Nova Scotia has a population of over 1 million with an incidence of cancer that is above average. Together, Nova Scotia Health and Varian aim to catalyze change and improve survival rates by building the oncology ecosystem of the future. The multi-disciplinary oncology partnership agreement reflects the synergistic value of the Siemens Healthineers and Varian combination, where the combined company is actively working on optimizing patient care across the cancer care pathway by pioneering solutions to enhance workflows, improve efficiencies, and make treatments more precise. Since December 2022, Varian and Nova Scotia Health have collaborated closely to build the foundation of a unified, connected cancer care network. With this agreement, Nova Scotia Health expands the scope of the previous oncology transformation agreement and will unify oncology patient data across oncology disciplines throughout the entire province by installing a suite of Varian software. From a single source, care teams across the province will possess a more holistic understanding of their patients and gain deeper insights to deliver more personalized care. To enhance adoption of these sophisticated technologies, Nova Scotia care teams will leverage Varian's Advanced Oncology Solutions (AOS) professional services to provide overall cancer operations support and to continue to advance the provincial oncology program. Furthermore, Nova Scotia Health will upgrade its radiation treatment systems to the state-of-the-art Ethos radiotherapy systems with HyperSight imaging. The Ethos system leverages artificial intelligence with the goal to improve precision and speed during treatment delivery. These products aim to expedite care decisions, enhance precision of treatment, and save patients time during treatment. The partnership also creates an opportunity for economic growth. Varian will establish a new office in Halifax in the first half of 2024 and has committed $50 million CAD in payroll and rent over the 10 years, providing a minimum of 60 jobs in Nova Scotia over that period. From its Nova Scotia office, Varian will work to develop a digital imaging concept, with feedback from Nova Scotia Health. In addition, Nova Scotia Health will be able to leverage the expertise of Siemens Healthineers in the area of artificial intelligence as an incubator for new products and solutions. If the digital imaging concept is successfully commercialized, Varian will establish an MDOP Innovation Fund for future Nova Scotia Health Innovation Hub projects. "Fixing healthcare in our province means keeping pace with the latest advancements in technology, equipment, and training," said Premier Tim Houston. "This partnership will foster a future where cancer care is a journey filled with hope, support, and unparalleled advancements." "We are so impressed with the magnitude and breadth of Nova Scotia Health's ambition to not only stay on the cusp of advances in cancer care but also contribute to creating those advances so that patients can receive better, more effective, more coordinated care," said Arthur Kaindl, Head of Varian. "This agreement brings to life our shared commitment to providing solutions across the cancer care continuum by addressing the needs of clinicians, program leaders, and the patients we all ultimately serve." Disclaimer: The term "Multi-disciplinary Oncology Partnership" and similar words used in this release does not imply, create, and/or establish a legal partnership or joint venture between Varian and Nova Scotia Health. VARIAN, ETHOS, and HYPERSIGHT are trademarks of Varian Medical Systems, Inc., pending or registered U.S. Pat. & Tm. Off. About Varian At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy, to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit . About Siemens Healthineers: Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2023, which ended on September 30, 2023, Siemens Healthineers had approximately 71,000 employees worldwide and generated revenue of around €21.7 billion. Further information is available at . About Nova Scotia Health Nova Scotia Health is the largest provider of health services in Nova Scotia. Our over 24,000 person workforce provides health care and support services in hospitals, health centres, and community-based programs across the province. Press Contacts Kristin Corey Varian Corporate Communications [email protected] Nova Scotia Health 1-844-483-3344 [email protected] SOURCE Varian

PALO ALTO, Calif., March 30, 2023 /PRNewswire/ -- Varian, a Siemens Healthineers company, today shared two key milestones as its users continue to adopt the new HyperSight™ imaging solution on the Ethos™ and Halcyon® radiotherapy systems: Health Canada has granted Investigational Testing Authorization for a clinical study at Nova Scotia Health evaluating potential benefits of HyperSight on an Ethos system. Varian has completed the first commercial installation in the world of a new Halcyon system equipped with HyperSight at Huntsman Cancer Institute. "We developed HyperSight to bring high-quality imaging inside the radiation treatment room, and believe this technology has the potential to be a game changer for cancer care teams and patients alike," said Kevin O'Reilly, President of Radiation Oncology Solutions at Varian. "We are committed to collaborating with our users and clinical partners to gather data that can help us better understand the role HyperSight can play in advancing care, and look forward to working together to make this technology available to more patients in need." Investigational Testing Authorization Granted for Clinical Study at Nova Scotia Health Examining Benefits of HyperSight on an Ethos System Health Canada has granted Investigational Testing Authorization for a clinical study evaluating the potential benefits of Varian's HyperSight imaging solution. The study will be conducted at Nova Scotia Health, the first site in the world to obtain HyperSight images of human trial participants on an Ethos therapy system. The Ethos system is designed to enable clinical teams to deliver adaptive radiotherapy, which allows the clinician to adjust the patient's treatment plan to reflect changes in the tumor or surrounding tissue, in real time during a typical treatment appointment. Images acquired on an Ethos system equipped with HyperSight can be used to inform and potentially enhance the adaptive radiotherapy workflow. The investigators at Nova Scotia Health will compare the quality of HyperSight images to cone-beam computed tomography (CBCT) images acquired from a standard CBCT imaging system on a TrueBeam® system. Additionally, they will evaluate the ability to accurately calculate radiation dose distributions directly from HyperSight CBCT images, which has not been possible with conventional CBCT images. "We are eager to evaluate the potential benefits of HyperSight, including how it may enhance the patient experience," said Dr. James Robar, Chief of Medical Physics at Nova Scotia Health, who also serves as chair of Varian's Intelligent Imaging Consortium. "The ability to acquire high-quality images during the normal course of treatment and in just six seconds provides an exciting opportunity to potentially deliver more efficient, comfortable care with the potential benefits of real-time treatment adaptation using Ethos. We look forward to continuing to collaborate with Varian to drive further adoption and innovation of this promising technology." First Commercial Install in the World of New Halcyon System Equipped with HyperSight Varian recently completed the first commercial installation of a new Halcyon system equipped with HyperSight at Huntsman Cancer Institute in Salt Lake City, Utah. Since installation, Huntsman Cancer Institute has treated several patients, including head and neck cancer patients, with the new Halcyon system. "We are impressed by the quality and speed of HyperSight image acquisition and the opportunity to revise treatment plans and adapt therapy efficiently. The possibilities and potential benefits of this technology are exciting – for both our team and our patients," said Shane Lloyd, MD, Associate Professor of Radiation Oncology at Huntsman Cancer Institute. About Varian At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 11,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit and follow @VarianMedSys on Twitter. Press Contact Katie Villany Varian Corporate Communications [email protected] SOURCE Varian